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Abstract
Increased expression of insulin-like growth factor-I (IGF-I) in embryonic neural progenitors in
vivo has been shown to accelerate neuron proliferation in the neocortex. In the present study, the in
vivo actions of (IGF-I) on naturally occurring neuron death in the cerebral cortex were investigated
during embryonic and early postnatal development in a line of transgenic (Tg) mice that overexpress
IGF-I in the brain, directed by nestin genomic regulatory elements, beginning at least as early as
embryonic day (E) 13. The areal density of apoptotic cells (NA, cells/mm2) at E16 in the telencephalic
wall of Tg and littermate control embryos was determined by immunostaining with an antibody
specific for activated caspase-3. Stereological analyses were conducted to measure the numerical
density (NV, cells/mm3) and total number of immunoreactive apoptotic cells in the cerebral cortex
of nestin/IGF-I Tg and control mice at postnatal days (P) 0 and 5. The volume of cerebral cortex and
both the NV and total number of all cortical neurons also were determined in both cerebral
hemispheres at P0, P5 and P270. Apoptotic cells were rare in the embryonic telencephalic wall at
E16. However, the overall NA of apoptotic cells was found to be significantly less by 46% in Tg
embryos. The volume of the cerebral cortex was significantly greater in Tg mice at P0 (30%), P5
(13%) and P270 (26%). The total number of cortical neurons in Tg mice was significantly increased
at P0 (29%), P5 (29%) and P270 (31%), although the NV of cortical neurons did not differ
significantly between Tg and control mice at any age. Transgenic mice at P0 and P5 exhibited
significant decreases in the NV of apoptotic cells in the cerebral cortex (31% and 39%, respectively).
The vast majority of these apoptotic cells (>90%) were judged to be neurons by their morphological
appearance. Increased expression of IGF-I inhibits naturally occurring (i.e. apoptotic) neuron death
during early postnatal development of the cerebral cortex to a degree that sustains a persistent increase
in total neuron number even in the adult animal.
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1. Introduction
Accumulating evidence indicates that insulin-like growth factor-I (IGF-I) has an important role
in brain growth and development. IGF-I is normally expressed in the developing rodent brain,
with expression detectable at least as early as embryonic day (E) 13 (Rotwein et al., 1988;
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Ayer-Le Lievre et al., 1991). Both IGF-I and its transmembrane receptor, the type 1 IGF
receptor, are expressed in the embryonic and postnatal rodent cerebral cortex, with peak
expression occurring between postnatal day (P) 0 and P28 (Ayer-Le Lievre et al., 1991; Bach
et al., 1991; Bondy, 1991; Bondy et al., 1992).
Multiple lines of evidence indicate that IGF-I is capable of stimulating brain growth. Analyses
of transgenic (Tg) mice, in which IGF-I is overexpressed in the brain, indicate that IGF-I acts
to increase brain weight and volume (Gutierrez-Ospina et al., 1996; Ye et al., 1996; Dentremont
et al., 1999; O’Kusky et al., 2000; Popken et al., 2004; Hodge et al., 2005). A number of in
vitro studies indicate that IGF-I promotes precursor proliferation of both neurons (Lenoir and
Honegger, 1983; DiCicco-Bloom and Black, 1988; Drago et al., 1991; Arsenijevic et al.,
2001) and oligodendrocytes (McMorris and Dubois-Dalcq, 1988; Mozell and McMorris,
1991). Increased neuron progenitor proliferation in the cerebral cortex stimulated by IGF-I also
has been demonstrated in vivo. In mice that overexpress IGF-I from early in embryonic
development under the control of nestin genomic regulatory elements, called nestin/IGF-I
transgenic (Tg) mice, the total number of neurons in the cerebral cortex is increased during
embryonic life (Popken et al., 2004), as a result of a shorter cell cycle length and an increased
rate of re-entry of progenitors into the mitotic cell cycle during cortical neurogenesis (Hodge
et al., 2004).
Both in vitro and in vivo studies (Aizeman and De Vellis, 1987; Torres-Aleman et al.,
1990a,b; Bozyczko-Coyne et al., 1993; Russell and Feldman, 1999; Takadera et al., 1999;
Chrysis et al., 2001; Yamada et al., 2001; Popken et al., 2004) also demonstrate that IGF-I
promotes cell survival through its anti-apoptotic actions. The extent to which an IGF-I-
mediated inhibition of apoptosis modulates neuron number is not known. We, therefore,
evaluated apoptosis during development in nestin/IGF-I Tg mice. In this line of Tg mice the
pattern of IGF-I overexpression is similar to the normal pattern of IGF-I expression in the brain
(Rotwein et al., 1988) in that transgene expression begins during embryonic development, rises
to a peak at P5–P10 and then decreases to a steady-state level by P20 (Popken et al., 2004).
2. Materials and methods
Nestin/IGF-I Tg mice were generated at the University of North Carolina at Chapel Hill as
described previously (Popken et al., 2004). These Tg mice carried a transgene composed of
regulatory regions of the human nestin gene, including the second intron of this gene, in
combination with the minimal promoter of the herpes simplex virus immediate early gene
ICP4, human IGF-IA cDNA, a signal sequence from rat somatostatin and polyadenylation
signals derived from the human growth hormone gene (Popken et al., 2004). Mice used in the
present studies were generated by breeding male heterozygous Tg mice with normal non-Tg
C57BL/6 female mice (Charles River Laboratories, Wilmington, MA). Litters derived from
these matings typically consisted of 50% Tg and 50% normal non-transgenic littermate control
mice. Tg mice were routinely identified by PCR of tail genomic DNA. All animal procedures
were conducted in accordance with guidelines specified by institutional review committees of
the University of British Columbia and the University of North Carolina at Chapel Hill. Efforts
were made to optimize experimental design so as to minimize the number of animal subjects
used and to alleviate pain and suffering.
Detailed analyses of the expression pattern of the nestin/IGF-I transgene have been reported
in a previous study (Popken et al., 2004). Briefly, expression of the nestin/IGF-I transgene was
evident in the CNS by as early as E13. At this time, the transgene was expressed in a number
of brain regions including the ventricular zone (VZ) of the developing cerebral wall, and
expression later became apparent in the cortical plate. During postnatal development, transgene
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expression was noted to be relatively homogenous throughout the cerebral cortex (Popken et
al., 2004).
2.1. Tissue collection
E16 embryos were obtained by hysterotomy from timed-pregnant dams after deep anesthesia
induced by intraperitoneal (i.p.) injections of ketamine (Ketalean, 100 mg/kg; Bimeda-MTC
Animal Health Inc., Cambridge, Ontario, Canada) and xylazine (Rompun, 10 mg/kg; Bayer
Inc., Toronto, Ontario, Canada). Heads were fixed overnight by immersion in 70% ethanol at
4 °C, and embedded in paraffin. Serial sections were cut at a thickness of 20 μm in the coronal
plane through the cerebral hemispheres and mounted individually on Colorfrost Plus glass
slides (Fisher Scientific, Ottawa, Ontario, Canada).
Mice at P0, P5 and P270 were anesthetized as described above and perfused through either the
left ventricle (P0, P5) or the ascending aorta (P270) with a fixative solution containing 4%
paraformaldehyde in 0.1 M phosphate buffer (pH 7.4) for 30 min at perfusion pressures of 50–
60 mmHg (P0), 60–70 mmHg (P5) or 100–110 mmHg (P270). Brains were weighed following
removal from the skull and post-fixed in additional fixative solution for 40 min (P0, P5) or for
24 h at 4 °C. Individual brains were cryoprotected by immersion in 30% sucrose in 0.1 M
phosphate buffer overnight at 4 °C. Serial frozen sections were cut at a thickness of 50 μm in
the coronal plane through the cerebral hemispheres, and individual sections were mounted on
chrome alum coated glass slides. Every fourth section in this series was stained for Nissl
substance using 0.1% thionine in acetate buffer (pH 3.7).
2.2. Assessment of apoptosis in the cerebral cortex at E16
Every 10th section through the brain was heated in antigen unmasking solution (Vector
Laboratories, Burlingame, CA) in a microwave oven for 10 min. Sections were then incubated
with polyclonal rabbit anti-cleaved caspase-3 primary antibody overnight at 4 °C (1:50 dilution;
Cell Signaling Technologies, Beverly, MA). This antibody specifically detects cleaved
caspase-3 and does not react with inactive forms of caspase-3 (e.g. procaspase-3) or with other
caspases. Detection of primary antibody binding was accomplished using an ABC Elite Kit
(Vector Laboratories) according to the manufacturer’s protocol. Sections were counterstained
with 0.1% aqueous basic fuchsin (Fisher Scientific). Sections processed without the addition
of primary antiserum were used as negative controls.
The areal density of apoptotic cells (NA, cells/mm2) in E16 Tg and control embryos (N = 4 per
group) was determined for the full height of the telencephalic wall, from the ventricular to the
pial surfaces. Sections were examined with an Olympus BH-2 compound microscope (10×
planapochromatic objective) interfaced to a Bioquant TCW98 image analysis system (R&M
Biometrics, Nashville, TN) and viewed at a final magnification of 188×. On each section, the
outline of the telencephalic wall corresponding to the cerebral cortex was traced using
established boundary criteria (Alvarez-Bolado and Swanson, 1996) and its area was measured
in μm2. Cleaved caspase-3 immunoreactive cells were counted on each section if they fell
within the outlined area of the cerebral wall. The number of apoptotic cells/mm2 was
determined as the total number of caspase-3 positive cells across all sections divided by the
sum of all area measurements. Mean cellular profile areas were determined for each mouse by
measuring the areas of cleaved caspase-3 immunoreactive cells in μm2, using a 100× oil-
immersion planapochromatic objective and viewed at a final magnification of 1880×. For all
variables measured at E16, statistical comparisons between control and Tg mice were
conducted using Student’s t-test.
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2.3. Assessment of apoptosis in the cerebral cortex at P0 and P5
From the serial frozen sections, every fourth section was processed for the detection of cleaved
caspase-3 immunoreactivity by incubating with polyclonal rabbit anti-cleaved caspase-3
primary antiserum (1:1500 dilution) overnight at room temperature. Sections were then
incubated in biotinylated goat anti-rabbit IgG secondary antibody (1:200) for 1 h at room
temperature. Further processing was carried out using a Vector Elite ABC kit (Vector
Laboratories) according to the manufacturer’s instructions, with DAB as the chromogen.
Sections were mounted on glass slides and lightly counterstained with 0.1% aqueous basic
fuchsin. Sections incubated without the addition of primary antiserum were used as negative
controls.
The total volume of the cerebral cortex was determined using Cavalieri’s direct estimator
(Gundersen et al., 1988a). Briefly, sections were examined with a 4× planapochromatic
objective at a final magnification of 75×, and the area of the cerebral cortex was traced and
measured in μm2 on each section. The total volume of the cerebral cortex was determined from
V = ΣA × T × 4, where ΣA is the sum of all area measurements, T is the section thickness (50
μm), and 4 is the periodicity of the section sample.
The NV and total number of cleaved caspase-3 immunoreactive cells in the cerebral cortex
were determined at P0 and P5 using the optical disector method (Gundersen et al., 1988b).
Briefly, sections were examined using a 100× oil-immersion planapochromatic objective at a
final magnification of 1880×. A square disector counting frame was focused approximately 3
μm below the section surface and moved through a set distance of section thickness in the Z-
axis. The dimensions of the disector counting frame were 25 μm × 25 μm × 20 μm, where 20
μm was the distance traveled in the Z-axis. Cells that came into focus entirely within the
counting frame and those cells that were intersected by the inclusion edges were scored. At
least 200–250 cells were counted for each animal. The NV of immunoreactive cells was
calculated from the equation NV = ΣQ−/ΣVDis, where ΣQ− is the sum of the cells counted and
VDis is the sum of the disector volumes. The disector volume was calculated from VDis =
aDis × h, where aDis is the area of the counting frame and h is the distance traveled in the Z-
axis plane (i.e. the disector height). The total number of cleaved caspase-3 immunoreactive
cells was calculated for each animal using the estimates of total cortical volume and NV of
caspase-3 immunoreactive cells. For P0 animals, studies were carried out on three animals per
group. For P5 animals, studies were carried out on three Tg animals and five control mice. For
all variables, statistical comparisons between control and Tg mice were conducted using 2 ×
2 (groups × ages) ANOVA.
2.4. NV and total number of cortical neurons at P0, P5 and P270
Stereological analyses were performed to measure the NV and total number of neurons in the
cerebral cortex of both hemispheres, using the serial sections stained for Nissl substance. Total
cortical volume was measured using Cavalieri’s direct estimator (Gundersen et al., 1988a), as
described above. The NV of neurons in the cerebral cortex was determined using the optical
disector method (Gundersen et al., 1988b). Neuron counts were conducted on seven sections
that were equally spaced along the caudal-to-rostral extent of the cerebral hemispheres. On
each section, a random set of sampling points was generated over the cerebral cortex (Bioquant
TCW98 stereology toolkit, R&M Biometrics). Approximately 15–20 points were sampled per
section. Sections were examined at individual points using a 100× oil-immersion
planapochromatic objective at a final magnification of 1880×. The disector counting frame
measured 15 μm × 15 μm × 10 μm for mice at P0, 25 μm × 25 μm × 10 μm for mice at P5, and
30 μm × 30 μm × 10 μm for mice at P270. At least 200–250 cells were counted for each animal.
The total number of neurons in the cerebral cortex was calculated for each animal using the
estimates of neuronal NV and total cortical volume.
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3.1. Apoptosis in the cerebral wall at E16
Very few apoptotic cells were observed in either Tg or control embryos in the embryonic
telencephalic wall corresponding to the primordial cerebral cortex. This paucity of apoptotic
cells precluded quantification using the disector method. Nonetheless, the areal density of
caspase-3 immunoreactive cells (cells/mm2 of section surface) could be assessed and was found
to be significantly less in Tg embryos as compared to controls (46%, P < 0.01). Mean values
(±S.E.M.) were 1.048 ± 0.154 cells/mm2 for Tg embryos and 1.943 ± 0.122 cells/mm2 for
controls, indicating that very few cells were undergoing apoptosis in either group. In both
groups, apoptotic cells were observed in all zones of the cerebral wall. However, more apoptotic
cells were generally located in the intermediate zone and cortical plate than in the proliferative
zones (VZ, SVZ).
The mean profile area of cleaved caspase-3 immunoreactive cells did not differ significantly
between groups on E16 (P > 0.05). The mean profile area of apoptotic cells was 22.73 ± 0.94
μm2 for Tg and 23.08 ± 0.36 μm2 for controls. Because the cell profile areas did not differ
significantly between Tg and control embryos, the probability of individual apoptotic cells
being intersected by the plane of section was roughly the same in both groups, and thus, these
estimates of NA were not biased by differences in cell size.
3.2. Apoptosis in the cerebral cortex during early postnatal development
Apoptotic cells were observed in all layers and cytoarchitectonic regions of the cerebral cortex
in Tg and control mice at P0 and P5. Although the overall density of apoptotic cells was visibly
lower in Tg mice at P0, a substantial number of cleaved caspase-3 immunoreactive cells were
observed in layer II/III of the cingulate and retrosplenial (agranular and granular) cortices in
both groups (Fig. 1). At P5, apoptotic cells were particularly apparent in layer II/III in the
cingulate, retrosplenial, frontal and primary motor regions of the cortex in both groups,
although they were observed at a lower density in Tg mice. Cleaved caspase-3 immunoreactive
cells also were observed in layer V in the primary motor and primary somatosensory regions,
and these cells had the morphological appearance of large pyramidal neurons. The general
distribution pattern of apoptotic cells within the cerebral cortex was similar in Tg and control
mice. Most of the cleaved caspase-3 immunoreactive cells in the cerebral cortex displayed
morphological characteristics of neurons, including dendritic arborizations (Fig. 2A and B).
Many cells displayed obvious neuronal characteristics, but had degenerated to the point where
cellular processes exhibited a distinctly beaded appearance (Fig. 2C). A small proportion of
labeled cells (<20%) exhibited short processes or no processes at all, and may have been either
apoptotic neurons or glia. In some cases, the labeled cells had degenerated to the point where
the cell body and processes were substantially degraded, indicating that apoptosis was quite
advanced (Fig. 2D). This type of cellular profile was always scored as a single cell.
The NV of cleaved caspase-3-immunoreactive cells in the cerebral cortex was analyzed at P0
and P5 using a 2 × 2 ANOVA comparison of Tg and control mice (Table 1). A main effect for
groups indicated that the NV of cleaved caspase-3 immunoreactive cells was decreased by 31–
39% in Tg mice (P < 0.001). A main effect of ages was also noted (P < 0.001), indicating that
the NV of apoptotic cells in the cortex was greater at P0 than at P5. The groups × ages interaction
was not significant (P = 0.07), so further individual group comparisons were not warranted.
Using estimates of the total cortical volume and the NV of apoptotic cells at P0 and P5, estimates
of the total number of apoptotic cells in the cortex were calculated for each mouse. Analysis
of the data using 2 × 2 ANOVA showed that the main effect for groups was not significant
(P > 0.05), indicating that the total number of apoptotic cells in the cortex did not differ between
Tg and control mice (Table 1). As well, the main effect for ages was not significant (P > 0.05),
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indicating that the total number of apoptotic cells in the cerebral cortex did not differ
significantly between P0 and P5 (Table 1).
3.3. Cortical volume, neuronal NV and total neuron number at P0 and P5
The increased expression of IGF-I in nestin/IGF-I transgenic mice resulted in increased brain
weight, but no change in body weight at P0 and P5 (Table 1). Stereological analysis of the
cerebral cortex revealed significantly greater cortical volume in Tg mice (P < 0.05), compared
to littermate controls (Table 1). The NV of neurons in the cerebral cortex did not differ
significantly between groups at either age studied (P > 0.05). However, analysis of the total
number of cortical neurons revealed a significant main effect for groups (P < 0.001), indicating
that total neuron number was increased in Tg mice. The total number of neurons in the cortex
was increased significantly in Tg mice by 29% at both P0 and P5.
3.4. Stereological analyses of the cerebral cortex at nine months of age
Stereological analyses were performed to measure the total volume, NV of neurons, and total
number of neurons in the cerebral cortex of nestin/IGF-I Tg and control mice at nine months
of age (Table 2). No signs of gross malformation or pathological abnormalities were apparent
in the brains of Tg mice. The brains of nestin/IGF-I Tg mice, however, were visibly larger than
those of littermate controls (Fig. 3). Brain weights of Tg mice were significantly greater (41%)
than those of control mice, but body weights did not differ significantly between groups (Table
2). The total volume of the cerebral cortex was significantly increased by 26% in Tg mice
compared to controls. The NV of neurons in the cortex did not differ significantly between
groups. However, total neuron number was significantly increased by 31% in nestin/IGF-I Tg
mice (Table 2), indicating that elevated IGF-I expression in Tg mice persistently augments
cortical neuron number into adult life, well beyond the period of naturally occurring neuron
death.
4. Discussion
As in previous reports (Srinivasan et al., 1998; DiCunto et al., 2000; Hu et al., 2000; Camarero
et al., 2001) this study employed immunohistochemical detection of activated caspase-3 to
identify neuronal apoptosis. Caspase-3 is expressed in the developing brain (Srinivasan et al.,
1998; De Bilbao et al., 1999), while defects in neuronal apoptosis have been demonstrated in
mice lacking the caspase-3 gene (Kuida et al., 1996). The results of the present study
demonstrate that elevated in vivo IGF-I expression promotes neuron survival in the cerebral
cortex during late prenatal and early postnatal development. As a result, the increased number
of cells accrued by accelerated proliferation during embryonic life (Hodge et al., 2004) is
maintained throughout postnatal life and into the adult. This finding is in agreement with
previous studies showing that IGF-I promotes neuron and glia survival in vitro (Aizeman and
De Vellis, 1987; Torres-Aleman et al., 1990a,b; Pons et al., 1991; Barres et al., 1992; Bozyczko-
Coyne et al., 1993; Sortino and Canonico, 1996; Russell and Feldman, 1999; Ye and D’Ercole,
1999; Yamada et al., 2001; Ness et al., 2002; Ness and Wood, 2002). It also is consistent with
a previous report showing that IGF-I overexpression during postnatal development reduced
the density of apoptotic cells in the cerebellum in vivo on P7 by decreasing procaspase-3 and
cleaved caspase-3 protein levels in the cerebellum (Chrysis et al., 2001). The current findings,
therefore, indicate that the increased neuron number documented in the present study and
previously in nestin/IGF-I Tg mice at P12 (Popken et al., 2004; Hodge et al., 2005) results, at
least in part, from an IGF-I-mediated enhancement of neuron survival.
In both Tg and control embryos, caspase-3 immunoreactive cells were observed so rarely in
the cerebral wall (i.e. on average, only 1 or 2 cells/mm2 of section area, respectively) that
unbiased stereological methods could not be used to estimate the NV of apoptotic cells.
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Attempts were made to measure the NV of apoptotic cells, using the disector method
(Gundersen et al., 1988b). However, in both Tg and control embryos, the number of apoptotic
cells in the entire cerebral cortex was not sufficient to allow for the use of this method, which
requires that at least 200 target cells be counted within representative random disector volumes
from each subject. It was found that, on average, the total number of apoptotic cells in the
telencephalic wall corresponding to the entire cerebral cortex for a given embryo was
substantially less than 200 cells, even if all sections in the series (on average, approximately
135 sections per embryo) were processed for immunohistochemistry. However, differences
between groups in our measurements of NA for caspase-3 immunoreactive cells in the
embryonic cerebral cortex likely correlate closely with differences in their NV. The mean
profile area of apoptotic cells did not differ significantly between groups (<2%), and there were
no consistent differences between groups in the apparent shape of these cellular profiles.
Therefore, apoptotic cells in both groups would have had roughly the same probability of being
intersected by the plane of section, and the 46% decrease in NA observed in Tg embryos likely
reflects a similar decrease in NV.
Augmented IGF-I expression during embryonic development reduces apoptosis by 46% in the
developing embryonic cerebral wall, at least at E16. In previous studies of nestin/IGF-I Tg
mice, the number of cells in the cortical plate at E16 was shown to be increased by 54% in Tg
embryos (Popken et al., 2004). The results of the present analysis indicate that an IGF-I-
mediated decrease in apoptosis probably contributes to the increase in cortical plate cell number
at E16. We also documented enhanced cell cycle progression and increased cell cycle re-entry
in the cerebral wall of these Tg embryos on E14–E15 (Hodge et al., 2004), indicating that
elevated IGF-I expression increased cortical plate cell number by stimulating neuron progenitor
proliferation during embryonic development of the cortex. The magnitude of apoptotic cell
death in neural precursors is a controversial issue, with previous studies showing varying
amounts of apoptosis in the embryonic brain. While studies using in situ end labeling
techniques (ISEL) to identify DNA double strand breaks suggest that 50–70% of the cells in
the embryonic cortex are eliminated by apoptosis (Blaschke et al., 1996), other reports, using
the TUNEL method, demonstrate that apoptosis is a rare event, with less than 9% of cortical
cells undergoing apoptosis on E16 (Thomaidou et al., 1997). The current findings are consistent
with analyses showing that a relatively small number of cells undergo apoptosis in the
embryonic cortex (Thomaidou et al., 1997; Verney et al., 2000).
IGF-I overexpression in Tg mice during postnatal development significantly decreases the
NV of apoptotic cells on P0 and P5 by 30–40%, as judged using an antibody that specifically
detects activated caspase-3. This reduction in the NV of apoptotic cells was slightly greater in
Tg mice at P5 (39%) than at P0 (31%). At these postnatal ages, the NV of cortical neurons does
not differ significantly between groups, indicating that the density of neurons in the cortex is
similar in both Tg and control mice. The documented reduction in the NV of apoptotic cells in
the cortex, without a parallel change in the NV of cortical neurons, therefore, corresponds to a
substantial decrease in the proportion of cells undergoing apoptosis in the cerebral cortex of
Tg mice. At the time of perfusion, approximately 68 cells per 100,000 on average were
observed to be undergoing apoptosis in control mice, while only 42 per 100,000 were apoptotic
in Tg mice. Given the significantly greater volume of the cerebral cortex in Tg mice, the total
number of apoptotic cells did not differ significantly.
This decrease in the proportion of apoptotic neurons in the cerebral cortex of Tg mice is not
likely due to increased brain growth, where a fixed number of apoptotic neurons is contained
in a larger population of cortical neurons, resulting from accelerated mitosis at earlier stages
of embryonic development. Neuronal apoptosis during the phase of programmed cell death in
early postnatal development is thought to be a mechanism for matching a population of
projection neurons to the size of its target field, and to be precipitated by inadequate
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neurotrophic support via decreased retrograde transport of growth factors from the target (for
reviews, see Cowan et al., 1984; Oppenheim, 1991; Burek and Oppenheim, 1996). In many
regions of the central nervous system, typically half of the neurons that are initially generated
through mitosis of precursors in a proliferative zone will degenerate at some point between
their migration into that specific region and their final maturation as distinguished by axon
outgrowth, synaptogenesis and myelination. However, the proportion of neurons undergoing
programmed cell death can vary substantially depending on the size of the target field.
Numerous studies have shown that full or partial ablation of the target will increase the
proportion of apoptotic neurons, while a supernumerary target (i.e. increased tissue volume,
increased numbers of neurons or muscle fibers) will decrease the proportion of apoptotic
neurons in the source region (Cowan et al., 1984). In nestin/IGF-I Tg mice, increased regional
tissue volumes and increased neuron numbers have been observed throughout the
telencephalon and diencephalon (Popken et al., 2004). There would appear to be little or no
mismatch between cortical neurons and their targets within these regions (i.e. callosal, cortico-
cortical, corticostriate, corticothalamic projections), and one would expect to see similar
proportions of apoptotic neurons in Tg and control mice. Given the caudal-to rostral gradient
in neurogenesis in the central nervous system and the fact that the nestin/IGF-I transgene in
these Tg mice begins expression at E13, one might expect to see a mismatch between cortical
neurons and their relatively smaller targets in the brainstem and spinal cord. However, a relative
reduction in target size in these regions would be expected to produce an increased proportion
of apoptotic cortical neurons in Tg mice, corresponding to corticobulbar and corticospinal
projections. The significant reduction in the proportion of apoptotic neurons observed in the
cerebral cortex of these Tg mice does not seem to result from simple brain growth. Rather, the
anti-apoptotic effects of elevated IGF-I in these Tg mice most likely result from a direct
inhibition of apoptosis mediated through Bcl-2 family proteins, which include both anti-
apoptotic (Bcl-2, Bcl-XL) and pro-apoptotic (Bad, Bax, Bim) members. Previous in vitro and
in vivo studies have shown that elevated levels of IGF-I act to reduce neuronal apoptosis by
increasing expression of Bcl-2 and Bcl-XL (Chrysis et al., 2001) and decreasing expression of
Bad, Bax and Bim (Gleichmann et al., 2000; Chrysis et al., 2001; Linseman et al., 2002), leading
to decreased activation of caspase-9 and caspase-3 (Takadera et al., 1999; Chrysis et al.,
2001; Linseman et al., 2002; Vincent et al., 2004; Zhong et al., 2004).
Neuron apoptosis was more prevalent in the cerebral cortex during early postnatal development
than during embryonic development in both Tg and control mice, consistent with a number of
other studies (Thomaidou et al., 1997; Verney et al., 2000; Spreafico et al., 1995). The peak
time of cortical neuron apoptosis documented in the present study differs somewhat from other
reports of cortical apoptosis in rodents. We found that the NV of apoptotic neurons was greater
at P0 than at P5 in both groups. Other studies have shown low levels of apoptosis in the mouse
cortex at birth, with apoptosis peaking at approximately P4 (Verney et al., 2000). Similarly,
the peak of neuron apoptosis in the cerebral cortex of rats has been shown to occur between
P5 and P8 (Spreafico et al., 1995). It is possible that these discrepancies among reports may
be explained by differences in the locations where apoptotic cells were counted. For example,
the data of Verney et al. (2000) were confined to multiple regions of the parietal cortex, whereas
the analysis reported here encompassed all cytoarchitectonic regions of the cortex. In both Tg
and control mice, the density of apoptotic cells was lowest at E16, rose to a peak at P0, and
declined thereafter. These data indicate that, while IGF-I decreases the density of apoptotic
neurons during postnatal development, the temporal pattern of apoptosis in the cortex is not
altered in Tg mice.
Transgene expression in nestin/IGF-I Tg mice decreases to a steady-state level by P20 (Popken
et al., 2004), raising the possibility that decreased transgene expression in these Tg mice may
increase their rate of neuronal apoptosis in the cerebral cortex during later stages of
development. To address this issue, stereological analyses of the cerebral cortex were
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performed in adult Tg and control mice at nine months of age (P270), well after the time when
transgene expression reaches steady-state levels. Our data indicate that neurons are not
eliminated in Tg mice during later phases of postnatal development, and that IGF-I does not
merely reduce the rate of elimination for normally extraneous cortical neurons. The NV of
neurons did not differ between nestin/IGF-I Tg and control mice at P270, or at any age in this
study. In both groups the NV of neurons decreased at successive ages, from approximately
600,000 at P0 to 180,000 at P270, as dendritic outgrowth and axon formation increased both
the volume of tissue and distance between neuronal cell bodies. A number of studies have
shown that increased expression of IGF-I in different lines of mice during postnatal
development results in decreased neuronal NV and increased process outgrowth in various
regions of the brain (Gutierrez-Ospina et al., 1996; Dentremont et al., 1999; O’Kusky et al.,
2000). The current results, therefore, suggest that elevated IGF-I expression in nestin/IGF-I
Tg mice does not augment process outgrowth sufficiently to reduce neuronal packing density.
This is likely due to the fact that peak transgene IGF-I in nestin/IGF-I Tg mice occurs during
late embryonic and early postnatal development, before extensive process outgrowth has
occurred. Alternatively, the cellular sites of IGF-I transgene expression in nestin/IGF-I Tg mice
may limit the availability of IGF-I at outgrowing processes. In any case, this finding clearly
differentiates nestin/IGF-I Tg mice from previously studied lines of IGF-I Tg mice.
The results of the present study indicate that IGF-I promotes neuron survival in the cerebral
cortex during embryonic and early postnatal development by decreasing the numerical density
and proportion of activated caspase-3 immunoreactive apoptotic neurons. These results
demonstrate that increased neuron number in the cerebral cortex of nestin/IGF-I Tg mice results
from both enhanced neuron progenitor proliferation primarily during embryonic development
(Hodge et al., 2004) and decreased neuron apoptosis primarily during early postnatal
development, and that this increase in neuron number is sustained in the adult brain.
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Representative photomicrographs illustrating the distribution of cleaved caspase-3
immunoreactive cells in the cerebral cortex of control (A) and nestin/IGF-I Tg (B) mice at P0.
The distribution of individual cleaved caspase-3 immunoreactive cells is demonstrated by
circles outlining individual cells. The middle caspase-3 immunoreactive neuron in the control
cortex (A) is illustrated at greater magnification in the inset. Sections are counterstained with
basic fuchsin. Scale bar = 250 μm; scale bar in inset = 10 μm.
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Photomicrographs of cleaved caspase-3 immunoreactive cells in the cerebral cortex at P5.
These sections were processed without counterstaining to enhance photographic contrast.
Some cleaved caspase-3 immunoreactive cells in the cerebral cortex at P0 and P5 exhibited
morphological hallmarks that were characteristic of neurons (see A and B), including extensive
dendritic arborizations. Other cells exhibited obvious neuronal characteristics, but exhibited
degeneration as evidenced by the disintegration of their processes (C). Yet other labeled cells
were observed, in which apoptosis appeared to be more advanced (D). These cells were
characterized by condensed cell bodies and more severely fragmented processes. Scale bar in
A = 10 μm and applies to all panels of the figure.
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Representative sections (30 μm thick), stained with thionine for Nissl substance, through the
cerebral hemispheres of nestin/IGF-I Tg (A) and non-Tg littermate control (B) mice at nine
months of age (P270). Note the increased size of the cerebral cortex in Tg mice with no apparent
difference in the packing of neurons. Scale bar = 1 mm.
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Table 1
Summary of morphometric variables for the cerebral cortex measured in nestin/IGF-I transgenic (Tg) and control
mice at postnatal day 0 and postnatal day 5
Postnatal day 0 Postnatal day 5
Control Nestin/IGF-I Tg Control Nestin/IGF-I Tg
Brain weight (mg) 77 ± 3 107 ± 3** 161 ± 6 186 ± 7**
Body weight (g) 1.29 ± 0.10 1.39 ± 0.05 3.14 ± 0.26 2.52 ± 0.16
Cortical volume
(mm3)
13.484 ± 0.702 17.576 ± 1.158* 38.245 ± 1.985 43.187 ± 1.195*
NV of neurons
(neurons/mm3)
611,546 ± 14,694 604,068 ± 8036 275,512 ± 20,696 311,897 ± 26,393
Total number of
neurons




430.73 ± 18.39 297.45 ± 8.09*** 184.66 ± 12.34 112.29 ± 19.13***
Total caspase-3+
cell number
5827 ± 500 5217 ± 288 7099 ± 696 4891 ± 972
All values are listed as the mean ± S.E.M. Volume, NV of neurons, and total number of neurons were measured bilaterally.
*
P < 0.05 for comparisons between Tg and control mice using 2 × 2 ANOVA.
**
P = 0.001 for comparisons between Tg and control mice using 2 × 2 ANOVA.
***
P < 0.001 for comparisons between Tg and control mice using 2 × 2 ANOVA.
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Table 2
Summary of morphometric variables measured in the cerebral cortex in nestin/IGF-I transgenic (Tg) and normal
littermate control mice at nine months of age (P270)
Control Nestin/IGF-I Tg
Body weight (g) 35.8 ± 5.9 33.6 ± 6.4
Brain weight (mg) 441 ± 10 622 ± 21*
Cortical volume (mm3) 78.45 ± 3.33 99.01 ± 3.63*
NV of neurons (neurons/mm
3) 181,228 ± 6976 188,423 ± 7139
Total number of neurons 14,175,559 ± 616,481 18,632,857 ± 852,892*
All values are listed as mean ± S.E.M. Volume, NV of neurons, and total number of neurons were measured bilaterally.
*
P < 0.01 for comparisons between Tg and control mice using Student’s t-test.
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